We are live on ! Find out more
PR

Payden & Rygel Portfolio holdings

AUM $1.3B
1-Year Est. Return 28.32%
This Fund
S&P 500
This Quarter Est. Return
+5.08%
1 Year Est. Return
+28.32%
3 Year Est. Return
+89.13%
5 Year Est. Return
+123.15%
10 Year Est. Return
+353.66%
AUM
$1.01B
AUM Growth
-$138M
Cap. Flow
-$174M
Cap. Flow %
-17.28%
Top 10 Hldgs %
26.38%
Holding
127
New
17
Increased
17
Reduced
26
Closed
9

Top Buys

Rank Stock Value
1
TXN icon
Texas Instruments
TXN
+$19.7M
2
GILD icon
Gilead Sciences
GILD
+$19.1M
3
LLY icon
Eli Lilly
LLY
+$16.1M
4
SO icon
Southern Company
SO
+$15.7M
5
HD icon
Home Depot
HD
+$15.2M

Top Sells

Rank Stock Value
1
RAI
Reynolds American Inc
RAI
+$26.3M
2
JNJ icon
Johnson & Johnson
JNJ
+$20.3M
3
CME icon
CME Group
CME
+$18M
4
IBM icon
IBM
IBM
+$17.9M
5
KO icon
Coca-Cola
KO
+$14.3M

Sector Composition

Rank Sector Weight
1 Financials 15.74%
2 Technology 12.46%
3 Healthcare 10.79%
4 Consumer Staples 10.29%
5 Energy 10%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JPM icon
1
JPMorgan Chase
JPM
$939B
$31.8M 3.16%
333,317
-12,900
-4% -$1.19M
LMT icon
2
Lockheed Martin
LMT
$134B
$31.8M 3.16%
102,500
-10,000
-9% -$2.98M
MO icon
3
Altria Group
MO
$122B
$29.4M 2.92%
463,284
+38,100
+9% +$2.54M
CSCO icon
4
Cisco
CSCO
$450B
$29.2M 2.9%
868,600
– –
CVX icon
5
Chevron
CVX
$388B
$26M 2.58%
221,050
+65,600
+42% +$7.16M
MSFT icon
6
Microsoft
MSFT
$2.84T
$25.5M 2.53%
341,700
– –
MCD icon
7
McDonald's
MCD
$188B
$25.4M 2.53%
162,200
– –
MRK icon
8
Merck
MRK
$324B
$22.5M 2.24%
368,582
-69,587
-16% -$4.22M
INTC icon
9
Intel
INTC
$466B
$22.4M 2.22%
587,400
+23,300
+4% +$828K
TXN icon
10
Texas Instruments
TXN
$255B
$21.5M 2.14%
+239,900
New +$19.7M
MXIM
11
DELISTED
Maxim Integrated Products
MXIM
$20.9M 2.08%
438,600
-4,100
-0.9% -$188K
PAYX icon
12
Paychex
PAYX
$40.4B
$20.4M 2.02%
339,800
– –
GILD icon
13
Gilead Sciences
GILD
$161B
$20.3M 2.02%
251,100
+249,700
+17,836% +$19.1M
PFE icon
14
Pfizer
PFE
$140B
$19.8M 1.97%
585,276
– –
COST icon
15
Costco
COST
$415B
$18.8M 1.87%
114,700
+55,000
+92% +$8.64M
BA icon
16
Boeing
BA
$165B
$18.6M 1.85%
73,300
– –
VZ icon
17
Verizon
VZ
$194B
$18.6M 1.85%
375,600
+73,200
+24% +$3.44M
EPD icon
18
Enterprise Products Partners
EPD
$83.8B
$18.3M 1.82%
701,200
+8,500
+1% +$225K
WFC icon
19
Wells Fargo
WFC
$261B
$17.8M 1.77%
322,100
-107,100
-25% -$5.69M
WM icon
20
Waste Management
WM
$95.9B
$17.7M 1.76%
225,800
– –
AEP icon
21
American Electric Power
AEP
$73.7B
$17.1M 1.7%
244,100
+41,200
+20% +$2.94M
LLY icon
22
Eli Lilly
LLY
$1.07T
$16.8M 1.67%
+195,900
New +$16.1M
LVS icon
23
Las Vegas Sands
LVS
$30.5B
$16.6M 1.65%
258,100
– –
HD icon
24
Home Depot
HD
$332B
$16.2M 1.61%
+99,000
New +$15.2M
SO icon
25
Southern Company
SO
$110B
$15.9M 1.58%
+322,900
New +$15.7M
1
2 3 4 5

Similar funds

GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
PWP
Private Wealth Partners Mill Valley, California $1.3B AUM 26.2% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
CCFM
Clear Creek Financial Management Silverdale, Washington $1.3B AUM 20.31% 1-Year Est. Return

Payden & Rygel's Q3 2017 Portfolio in Review

As of Q3 2017, Payden & Rygel held 127 positions worth $1.01B, down 12% from $1.14B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Payden & Rygel withdrew a net $174M in Q3 2017, closing 9 positions and reducing 26 holdings. Its most notable exit was Reynolds American Inc, an estimated $26.3M position sold in full.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 10% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Payden & Rygel opened a new position in Texas Instruments worth $21.5M.

  • Payden & Rygel's largest Q3 2017 buy was Texas Instruments: 239,900 shares worth $21.5M.
  • Payden & Rygel added most to Gilead Sciences in Q3 2017, an estimated $19.1M increase.
  • Payden & Rygel's biggest Q3 2017 reduction was Johnson & Johnson, cutting an estimated $20.3M.
  • Payden & Rygel fully exited Reynolds American Inc in Q3 2017, selling an estimated $26.3M.
  • Payden & Rygel's ten largest holdings make up 26% of its $1.01B portfolio in Q3 2017.
  • Payden & Rygel opened 17 new positions and closed 9 in Q3 2017.
  • Payden & Rygel's portfolio value fell 12% quarter-over-quarter to $1.01B.

Based on Payden & Rygel's 13F filing for Q3 2017, filed 14 Nov 2017.